Grossi G - Search Results

1

Small Molecule Tyrosine Kinase Inhibitors (TKIs) for Glioblastoma Treatment.

Frumento D, Grossi G, Falesiedi M, Musumeci F, Carbone A, Schenone S. Frumento D, et al. Among authors: grossi g. Int J Mol Sci. 2024 Jan 23;25(3):1398. doi: 10.3390/ijms25031398. Int J Mol Sci. 2024. PMID: 38338677 Free PMC article. Review.

2

Analogs, formulations and derivatives of imatinib: a patent review.

Musumeci F, Schenone S, Grossi G, Brullo C, Sanna M. Musumeci F, et al. Among authors: grossi g. Expert Opin Ther Pat. 2015;25(12):1411-21. doi: 10.1517/13543776.2015.1089233. Epub 2015 Sep 15. Expert Opin Ther Pat. 2015. PMID: 26372795 Review.

3

Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma.

Musumeci F, Fallacara AL, Brullo C, Grossi G, Botta L, Calandro P, Chiariello M, Kissova M, Crespan E, Maga G, Schenone S. Musumeci F, et al. Among authors: grossi g. Eur J Med Chem. 2017 Feb 15;127:369-378. doi: 10.1016/j.ejmech.2016.12.036. Epub 2016 Dec 19. Eur J Med Chem. 2017. PMID: 28076826

4

Pyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors.

Musumeci F, Sanna M, Grossi G, Brullo C, Fallacara AL, Schenone S. Musumeci F, et al. Among authors: grossi g. Curr Med Chem. 2017;24(19):2059-2085. doi: 10.2174/0929867324666170303162100. Curr Med Chem. 2017. PMID: 28266267 Review.

5

An Update on JAK Inhibitors.

Musumeci F, Greco C, Giacchello I, Fallacara AL, Ibrahim MM, Grossi G, Brullo C, Schenone S. Musumeci F, et al. Among authors: grossi g. Curr Med Chem. 2019;26(10):1806-1832. doi: 10.2174/0929867325666180327093502. Curr Med Chem. 2019. PMID: 29589523 Review.

6

Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction.

D'Agostino I, Giacchello I, Nannetti G, Fallacara AL, Deodato D, Musumeci F, Grossi G, Palù G, Cau Y, Trist IM, Loregian A, Schenone S, Botta M. D'Agostino I, et al. Among authors: grossi g. Eur J Med Chem. 2018 Sep 5;157:743-758. doi: 10.1016/j.ejmech.2018.08.032. Epub 2018 Aug 13. Eur J Med Chem. 2018. PMID: 30142611

7

Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid Leukemia.

Musumeci F, Greco C, Grossi G, Molinari A, Schenone S. Musumeci F, et al. Among authors: grossi g. Cancers (Basel). 2018 Nov 9;10(11):430. doi: 10.3390/cancers10110430. Cancers (Basel). 2018. PMID: 30423915 Free PMC article. Review.

8

Insights into RNA-dependent RNA Polymerase Inhibitors as Antiinfluenza Virus Agents.

Giacchello I, Musumeci F, D'Agostino I, Greco C, Grossi G, Schenone S. Giacchello I, et al. Among authors: grossi g. Curr Med Chem. 2021;28(6):1068-1090. doi: 10.2174/0929867327666200114115632. Curr Med Chem. 2021. PMID: 31942843 Review.

9

Pyrazole[3,4-d]pyrimidine derivatives loaded into halloysite as potential CDK inhibitors.

Massaro M, Barone G, Barra V, Cancemi P, Di Leonardo A, Grossi G, Lo Celso F, Schenone S, Viseras Iborra C, Riela S. Massaro M, et al. Among authors: grossi g. Int J Pharm. 2021 Apr 15;599:120281. doi: 10.1016/j.ijpharm.2021.120281. Epub 2021 Jan 29. Int J Pharm. 2021. PMID: 33524522

10

Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of Neuroblastoma.

Musumeci F, Cianciusi A, D'Agostino I, Grossi G, Carbone A, Schenone S. Musumeci F, et al. Among authors: grossi g. Molecules. 2021 Nov 23;26(23):7069. doi: 10.3390/molecules26237069. Molecules. 2021. PMID: 34885651 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

533 results

Search Page